NM_005592.4:c.299C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005592.4(MUSK):​c.299C>T​(p.Thr100Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0269 in 1,613,722 control chromosomes in the GnomAD database, including 711 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T100T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.021 ( 44 hom., cov: 31)
Exomes 𝑓: 0.027 ( 667 hom. )

Consequence

MUSK
NM_005592.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.213

Publications

19 publications found
Variant links:
Genes affected
MUSK (HGNC:7525): (muscle associated receptor tyrosine kinase) This gene encodes a muscle-specific tyrosine kinase receptor. The encoded protein may play a role in clustering of the acetylcholine receptor in the postsynaptic neuromuscular junction. Mutations in this gene have been associated with congenital myasthenic syndrome. Alternatively spliced transcript variants have been described.[provided by RefSeq, Oct 2009]
MUSK Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 9
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • fetal akinesia deformation sequence 1
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0064065754).
BP6
Variant 9-110687209-C-T is Benign according to our data. Variant chr9-110687209-C-T is described in ClinVar as Benign. ClinVar VariationId is 129634.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0213 (3236/152218) while in subpopulation NFE AF = 0.0324 (2206/68016). AF 95% confidence interval is 0.0313. There are 44 homozygotes in GnomAd4. There are 1504 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 44 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MUSKNM_005592.4 linkc.299C>T p.Thr100Met missense_variant Exon 3 of 15 ENST00000374448.9 NP_005583.1 O15146-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MUSKENST00000374448.9 linkc.299C>T p.Thr100Met missense_variant Exon 3 of 15 5 NM_005592.4 ENSP00000363571.4 O15146-1
MUSKENST00000416899.7 linkc.299C>T p.Thr100Met missense_variant Exon 3 of 14 5 ENSP00000393608.3 A0A087WSY1
MUSKENST00000189978.10 linkc.299C>T p.Thr100Met missense_variant Exon 3 of 14 5 ENSP00000189978.6 O15146-2
MUSKENST00000374439.1 linkc.-8C>T upstream_gene_variant 5 ENSP00000363562.2 F6XAJ2

Frequencies

GnomAD3 genomes
AF:
0.0213
AC:
3236
AN:
152100
Hom.:
44
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00625
Gnomad AMI
AF:
0.00987
Gnomad AMR
AF:
0.0191
Gnomad ASJ
AF:
0.0259
Gnomad EAS
AF:
0.00174
Gnomad SAS
AF:
0.00311
Gnomad FIN
AF:
0.0290
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0324
Gnomad OTH
AF:
0.0196
GnomAD2 exomes
AF:
0.0230
AC:
5741
AN:
249182
AF XY:
0.0230
show subpopulations
Gnomad AFR exome
AF:
0.00568
Gnomad AMR exome
AF:
0.0123
Gnomad ASJ exome
AF:
0.0276
Gnomad EAS exome
AF:
0.00362
Gnomad FIN exome
AF:
0.0310
Gnomad NFE exome
AF:
0.0348
Gnomad OTH exome
AF:
0.0246
GnomAD4 exome
AF:
0.0274
AC:
40103
AN:
1461504
Hom.:
667
Cov.:
31
AF XY:
0.0269
AC XY:
19524
AN XY:
727020
show subpopulations
African (AFR)
AF:
0.00463
AC:
155
AN:
33474
American (AMR)
AF:
0.0125
AC:
561
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.0253
AC:
661
AN:
26134
East Asian (EAS)
AF:
0.00146
AC:
58
AN:
39698
South Asian (SAS)
AF:
0.00450
AC:
388
AN:
86250
European-Finnish (FIN)
AF:
0.0309
AC:
1648
AN:
53386
Middle Eastern (MID)
AF:
0.0179
AC:
103
AN:
5764
European-Non Finnish (NFE)
AF:
0.0315
AC:
35010
AN:
1111714
Other (OTH)
AF:
0.0252
AC:
1519
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
2037
4074
6111
8148
10185
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1238
2476
3714
4952
6190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0213
AC:
3236
AN:
152218
Hom.:
44
Cov.:
31
AF XY:
0.0202
AC XY:
1504
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.00623
AC:
259
AN:
41546
American (AMR)
AF:
0.0190
AC:
291
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0259
AC:
90
AN:
3472
East Asian (EAS)
AF:
0.00174
AC:
9
AN:
5170
South Asian (SAS)
AF:
0.00311
AC:
15
AN:
4822
European-Finnish (FIN)
AF:
0.0290
AC:
307
AN:
10592
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0324
AC:
2206
AN:
68016
Other (OTH)
AF:
0.0199
AC:
42
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
163
327
490
654
817
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0284
Hom.:
245
Bravo
AF:
0.0204
TwinsUK
AF:
0.0286
AC:
106
ALSPAC
AF:
0.0322
AC:
124
ESP6500AA
AF:
0.00714
AC:
29
ESP6500EA
AF:
0.0302
AC:
254
ExAC
AF:
0.0238
AC:
2880
Asia WGS
AF:
0.00318
AC:
11
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Dec 13, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 05, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Fetal akinesia deformation sequence 1;C4225368:Congenital myasthenic syndrome 9 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital myasthenic syndrome 9 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
12
DANN
Benign
0.85
DEOGEN2
Benign
0.13
T;.;.;.
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.026
N
LIST_S2
Uncertain
0.91
D;D;D;D
MetaRNN
Benign
0.0064
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.97
L;.;L;.
PhyloP100
0.21
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-0.11
N;N;N;.
REVEL
Benign
0.11
Sift
Benign
0.23
T;T;T;.
Sift4G
Benign
0.12
T;T;T;T
Polyphen
0.16
B;.;.;.
Vest4
0.092
MPC
0.19
ClinPred
0.0073
T
GERP RS
-7.1
PromoterAI
0.0018
Neutral
Varity_R
0.039
gMVP
0.46
Mutation Taster
=298/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35142681; hg19: chr9-113449489; COSMIC: COSV105049818; COSMIC: COSV105049818; API